Literature DB >> 3998031

High-performance liquid chromatographic procedure for the determination of a new antithrombotic and vasodilating agent, cilostazol, in human plasma.

H Akiyama, S Kudo, M Odomi, T Shimizu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3998031     DOI： 10.1016/0378-4347(85)80121-3

Source DB:  PubMed          Journal:  J Chromatogr


× No keyword cloud information.
  4 in total

1.  Effect of omeprazole on the metabolism of cilostazol.

Authors:  A Suri; S L Bramer
Journal:  Clin Pharmacokinet       Date:  1999       Impact factor: 6.447

2.  Effect of cilostazol on experimental diabetic neuropathy in the rat.

Authors:  M Kihara; J D Schmelzer; P A Low
Journal:  Diabetologia       Date:  1995-08       Impact factor: 10.122

3.  Cilostazol activates function of bone marrow-derived endothelial progenitor cell for re-endothelialization in a carotid balloon injury model.

Authors:  Rie Kawabe-Yako; Masaaki Ii; Ii Masaaki; Osamu Masuo; Takayuki Asahara; Toru Itakura
Journal:  PLoS One       Date:  2011-09-12       Impact factor: 3.240

4.  Determination of cilostazol and its active metabolite 3,4-dehydro cilostazol from small plasma volume by UPLC-MS/MS.

Authors:  Nejal M Bhatt; Vijay D Chavada; Daxesh P Patel; Primal Sharma; Mallika Sanyal; Pranav S Shrivastav
Journal:  J Pharm Anal       Date:  2014-08-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.